Display options
Share it on

Ann Hematol. 2018 Jul;97(7):1299. doi: 10.1007/s00277-018-3340-7.

Correction to: MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia.

Annals of hematology

Xiaolu Zhang, Bingnan Li, Jingya Yu, Jenny Dahlström, Anh Nhi Tran, Magnus Björkholm, Dawei Xu

Affiliations

  1. Center for Hematology, Department of Medicine and Center for Molecular Medicine, Karolinska University Hospital Solna and Karolinska Institutet, SE-171 76, Stockholm, Sweden.
  2. Department of Clinical Genetics, Karolinska University Hospital and Karolinska Institutet, SE-171 76, Stockholm, Sweden.
  3. Center for Hematology, Department of Medicine and Center for Molecular Medicine, Karolinska University Hospital Solna and Karolinska Institutet, SE-171 76, Stockholm, Sweden. [email protected].

PMID: 29744585 PMCID: PMC6828086 DOI: 10.1007/s00277-018-3340-7

Abstract

The original version of this article contained a mistake. The name of Magnus Björkhom should have been Magnus Björkholm.

Publication Types